Validation of tissue microarray technology in malignant peripheral nerve sheath tumours

Journal of Clinical Pathology

Volumn 62, Issue 7, 2009, Pages 629-633

  Soares Goncalves Cunha K ^a,b,f   Cunha Caruso, A ^c   Soares Goncalves A ^a   Goncalves Bernardo V ^a   Rodrigues Cordovil Pires, A ^a   Carvalho Da Fonseca, E ^a   Antonio Silvestre De Faria P ^c   Esmeraldo Da Silva, L ^a   Geller, M ^b,d,e   Soares De Moura Neto, R ^e   Silami Lopes, V ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b Carlos Chagas Institute   (Brazil)

^c INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^d Department of Microbiology and Immunology   (Brazil)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PARAFFIN; POLYCLONAL ANTIBODY; PROTEIN S 100;

ADULT; AGED; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; DIGITAL IMAGING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; NERVE BIOPSY; NERVE SHEATH TUMOR; PERIPHERAL NERVE TUMOR; PRIORITY JOURNAL; TISSUE MICROARRAY; TISSUE SECTION; VALIDATION STUDY;

BIOPSY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; NEOPLASM PROTEINS; NERVE SHEATH NEOPLASMS; PARAFFIN EMBEDDING; REPRODUCIBILITY OF RESULTS; S100 PROTEINS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 67650434354     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.063081     Document Type: Article

References (33)

1. Scheithauer BW, Woodruff JM, Erlandson RA. Tumors of the peripheral nervous system. Washington DC: AFIP, 1999:303-372
2. Bilgic B, Ates LE, Demiryont M, et al. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1. Pathol Oncol Res 2003;9:201-205 (Pubitemid 37429504)
3. Korf BR. Neurofibromas and malignant tumors of the peripheral nerve sheath. In: Friedman JM, Gutmann DH, MacCollin M, et al., eds Neurofibromatosis. Phenotype, natural history and pathogenesis. Baltimore: the Johns Hopkins University Press, 1999:142-161
4. Crowe FW, Schull WJ, Neel JV. A Clinical, pathological and genetic study of multiple neurofibromatosis. Springfield, IL: Charles C Thomas,1956:3-181.
5. Poyhonen M, Kytölä S, Leisti J. Epidemiology of neurofibromatosis type 1 (NF1) in northern Finland. J Med Genet 2000;37:632-636 (Pubitemid 30604109)
6. Ducatman BS, Scheithauer BW, Piepgras DG, et al. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986;57:2006-2021
7. Gonzales-Gomez P, Bello JM, Arjona D, et al. Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas. Oncol Rep 2003;10:1519-1523
8. Lévy P, Vidaud D, Leroy K, et al. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale realtime RT-PCR. Mol Cancer 2004;3:20. (Pubitemid 40230552)
9. Karube K, Nabeshima K, Ishiguro M, et al. cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours. J Clin Pathol 2006;59:160-165 (Pubitemid 43235581)
10. Kourea HP, Cordon-Cardo C, Dudas M, et al. Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas. Am J Pathol 1999;55:1885-1891.
11. Mawrin C, Kirches E, Boltze C, et al. Immunohistochemical and molecular analysis of p53, RB, and PTEN in malignant peripheral nerve sheath tumors. Virchows Arch 2002;440:610-615
12. Frahm S, Mautner VF, Brems H, et al. Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients. Neurobiol Dis 2004;16:85-91. (Pubitemid 38569799)
13. Tawfik El-Mansi M, Williams AR. Validation of tissue microarray technology using cervical adenocarcinoma and its precursors as a model system. Int J Gynecol Cancer 2006;16:1225-1233 (Pubitemid 43886750)
14. Fons G, Hasibuan SM, van der Velden, et al. Validation of tissue microarray technology in endometrioid cancer of the endometrium. J Clin Pathol 2007;60:500-503 (Pubitemid 46867158)
15. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-847 (Pubitemid 28331029)
16. Camp RL, Chartte LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943-1949 (Pubitemid 32012762)
17. Hedvat CV, Hegde A, Chaganti RSK, et al. Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma. Hum Pathol 2002;33:968-974 (Pubitemid 35215839)
18. Pires AR, Andreiuolo FM, De Souza SR. TMA for all: a new method for the construction of tissue microarrays without recipient paraffin block using custom-built needles. Diagn Pathol 2006;1:14.
19. Su Y, Shrubsole MJ, Ness RM, et al. Immunohistochemical expressions of Ki-67, cyclin D1, beta-catenin, cyclooxygenase-2, and epidermal growth factor receptor in human colorectal adenoma: a validation study of tissue microarrays. Cancer Epidemiol Biomarkers Prev 2006;15:1719-1726 (Pubitemid 44497109)
20. Ismail NI, Kaur G, Hashim H, et al. Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progression. Cancer Cell Int 2008;8:6. (Pubitemid 351761674)
21. Graham AD, Faratian D, Rae F, et al. Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization. Histopathology 2008;52:847-855 (Pubitemid 351724917)
22. Hassan S, Ferrario C, Mamo A, et al. Tissue microarrays: emerging standard for biomarker validation. Curr Opin Biotechnol 2008;19:19-25. (Pubitemid 351226513)
23. Rubin MA, Dunn R, Strawderman M, et al. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 2002;26:312-319 (Pubitemid 34184454)
24. Engellau J, Bendahl PO, Persson A, et al. Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays. Hum Pathol 2005;36:994-1002. (Pubitemid 41253386)
25. Maseide K, Pintilie M, Kandel R, et al. Can sparsely and heterogeneously expressed proteins be detected using tissue microarrays? A simulation study of the hypoxia marker carbonic anhydrase IX (CA IX) in human soft tissue sarcoma. Pathol Res Pract 2008;204:175-183
26. Nielsen TO, Hsu DF, O'Connell, et al. Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. Am J Pathol 2003;163:1449-1456 (Pubitemid 37175092)
27. Olsen SH, Thomas DG, Lucas DR. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Mod Pathol 2006;19:659-668
28. Sabah M, Cummins R, Leader M, et al. Immunoreactivity of p53, Mdm2, p21(WAF1/ CIP1) Bcl-2, and Bax in soft tissue sarcomas: correlation with histologic grade. Appl Immunohistochem Mol Morphol 2007;15:64-69
29. Camisasca DR, Honorato J, Bernardo V, et al. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma. Oral Oncol 2009;45:225-233
30. De Jong D, Rosenwald A, Chhanabhai M, et al. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications: a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol 2007;25:805-812 (Pubitemid 350002880)
31. Boone J, van Hillegersberg R, van Diest PJ, et al. Validation of tissue microarray technology in squamous cell carcinoma of the esophagus. Virchows Arch 2008;452:507-514
32. Van Den Eynden GG, van der Auwera, van Laere S, et al. Validation of a tissue microarray to study differential protein expression in inflammatory and noninflammatory breast cancer. Breast Cancer Res Treat 2004;85:13-22. (Pubitemid 38437979)
33. Fernebro E, Dictor M, Bendahl PO, et al. Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer. Arch Pathol Lab Med 2002;126:702-705 (Pubitemid 34602572)